We have previously shown that NSCLC cell treatment with epinephrine or nicotine resulted in activation of EGFR and IGF-1R, an effect opposite to that found by cell treatment with propranolol [37]. This evidence concerns the gene IGF1R and non-small cell lung carcinoma.